Jay O. Knipe
About
Jay O. Knipe is a scholar working on Infectious Diseases, Molecular Biology and Hepatology.
According to data from OpenAlex, Jay O. Knipe has authored 41 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Molecular Biology and 12 papers in Hepatology. Recurrent topics in Jay O. Knipe's work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (11 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jay O. Knipe is often cited by papers focused on Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (11 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jay O. Knipe collaborates with scholars based in United States, Germany and Switzerland. Jay O. Knipe's co-authors include Kathleen Mosure, Nicholas A. Meanwell, Raymond A. Firestone, David Willner, Gene M. Dubowchik, Krishnaswamy Yeleswaram, Richard J. Colonno, Pamela A. Trail, Sandra J. Hofstead and Shirley J. Lasch and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Medicinal Chemistry.
In The Last Decade
Jay O. Knipe
41 papers receiving 2.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jay O. Knipe United States | 23 | 867 | 785 | 727 | 637 | 592 | 41 | 2.8k | ||
| George D. Hartman United States | 40 | 2.5k 2.9× | 466 0.6× | 1.7k 2.3× | 575 0.9× | 508 0.9× | 183 | 5.4k | ||
| Daniel F. Wyss United States | 31 | 1.6k 1.8× | 165 0.2× | 382 0.5× | 173 0.3× | 323 0.5× | 58 | 3.4k | ||
| Gunnar Lindeberg Sweden | 30 | 1.4k 1.6× | 126 0.2× | 632 0.9× | 149 0.2× | 346 0.6× | 89 | 2.7k | ||
| Wieslaw M. Kazmierski United States | 25 | 2.8k 3.2× | 111 0.1× | 1.2k 1.6× | 162 0.3× | 302 0.5× | 73 | 3.8k | ||
| Yonghui Zhang China | 35 | 1.6k 1.9× | 117 0.1× | 313 0.4× | 313 0.5× | 511 0.9× | 94 | 3.2k | ||
| Carston R. Wagner United States | 36 | 2.6k 3.0× | 60 0.1× | 655 0.9× | 265 0.4× | 355 0.6× | 129 | 3.8k | ||
| Shashi Gujar Canada | 36 | 1.6k 1.8× | 115 0.1× | 424 0.6× | 448 0.7× | 1.9k 3.2× | 86 | 4.6k | ||
| Lee M. Greenberger United States | 44 | 2.9k 3.3× | 62 0.1× | 949 1.3× | 127 0.2× | 3.2k 5.4× | 92 | 5.9k | ||
| James H. Nettles United States | 20 | 1.2k 1.4× | 108 0.1× | 505 0.7× | 99 0.2× | 729 1.2× | 33 | 2.5k | ||
| Yoshito Abe Japan | 31 | 2.0k 2.3× | 116 0.1× | 343 0.5× | 188 0.3× | 267 0.5× | 129 | 3.2k |
Countries citing papers authored by Jay O. Knipe
Since
Specialization
Citations
This map shows the geographic impact of Jay O. Knipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay O. Knipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay O. Knipe more than expected).
Fields of papers citing papers by Jay O. Knipe
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jay O. Knipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay O. Knipe. The network helps show where Jay O. Knipe may publish in the future.
Co-authorship network of co-authors of Jay O. Knipe
This figure shows the co-authorship network connecting the top 25 collaborators of Jay O. Knipe. A scholar is included among the top collaborators of Jay O. Knipe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay O. Knipe. Jay O. Knipe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hiebert, Sheldon, Jacques Friborg, Fei Yu, et al.. (2017). The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 28(1). 43–48.
2.
Chen, Jie, Qian Zhao, Li‐Qiang Sun, et al.. (2016). Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 27(3). 590–596.
3.
Mosure, Kathleen, Jay O. Knipe, Vinod Arora, et al.. (2015). Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. Journal of Pharmaceutical Sciences. 104(9). 2813–2823.
4.
Eastman, Kyle J., Zhong Yang, John A. Bender, et al.. (2014). Identification of a novel series of potent HCV NS5B Site I inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(8). 1993–1997.
5.
Ding, Min, Feng He, Thomas W. Hudyma, et al.. (2012). Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(8). 2866–2871.
6.
McPhee, Fiona, Amy K. Sheaffer, Jacques Friborg, et al.. (2012). Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032). Antimicrobial Agents and Chemotherapy. 56(10). 5387–5396.
7.
Gao, Min, Richard E. Nettles, Makonen Belema, et al.. (2010). Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature. 465(7294). 96–100.
8.
Drexler, Dieter M., et al.. (2008). An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion. Assay and Drug Development Technologies. 6(1). 121–129.
9.
Knipe, Jay O. & Kathleen Mosure. (2008). Nonclinical pharmacokinetics of BMS‐292655, a water‐soluble prodrug of the antifungal ravuconazole. Biopharmaceutics & Drug Disposition. 29(5). 270–279.
10.
Han, Xiaojun, Rita L. Civiello, Sokhom S. Pin, et al.. (2007). An orally active corticotropin releasing factor 1 receptor antagonist from 8-aryl-1,3a,7,8-tetraaza-cyclopenta[a]indenes. Bioorganic & Medicinal Chemistry Letters. 17(7). 2026–2030.
11.
Sun, Li‐Qiang, Jie Chen, Lawrence G. Iben, et al.. (2004). N-{2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl}acetamide: an orally bioavailable melatonin receptor agonist. Bioorganic & Medicinal Chemistry Letters. 14(20). 5157–5160.
12.
Hewawasam, Piyasena, Min Ding, Dalton King, et al.. (2003). Synthesis of water-Soluble prodrugs of BMS-191011: A maxi-K channel opener targeted for post-stroke neuroprotection. Bioorganic & Medicinal Chemistry Letters. 13(10). 1695–1698.
13.
Hewawasam, Piyasena, Valentin K. Gribkoff, Steven I. Dworetzky, et al.. (2002). The synthesis and characterization of BMS-204352 (MaxiPost™) and related 3-fluorooxindoles as openers of maxi-K potassium channels. Bioorganic & Medicinal Chemistry Letters. 12(7). 1023–1026.
14.
Hewawasam, Piyasena, Wenhong Fan, Jay O. Knipe, et al.. (2002). The synthesis and structure–activity relationships of 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-Dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection. Bioorganic & Medicinal Chemistry Letters. 12(13). 1779–1783.
15.
Dubowchik, Gene M., Kathleen Mosure, Jay O. Knipe, & Raymond A. Firestone. (1998). Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol®), mitomycin C and doxorubicin. Bioorganic & Medicinal Chemistry Letters. 8(23). 3347–3352.
16.
Mosure, Kathleen, Arris J. Henderson, Lewis J. Klunk, & Jay O. Knipe. (1997). Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248). Cancer Chemotherapy and Pharmacology. 40(3). 251–258.
17.
Yeleswaram, Krishnaswamy, et al.. (1997). Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. Journal of Pineal Research. 22(1). 45–51.
18.
Vyas, Dolatrai M., Henry Ν. C. Wong, Alfred R. Crosswell, et al.. (1993). Synthesis and antitumor evaluation of water soluble taxol phosphates. Bioorganic & Medicinal Chemistry Letters. 3(6). 1357–1360.
19.
Kaneko, Takushi, David Willner, Ivo Monković, et al.. (1991). New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity. Bioconjugate Chemistry. 2(3). 133–141.
20.
Braslawsky, Gary R., Kathleen F. Kadow, Jay O. Knipe, et al.. (1991). Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity. Cancer Immunology Immunotherapy. 33(6). 367–374.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by George D. Hartman Breakdown of academic impact, for papers by Daniel F. Wyss Breakdown of academic impact, for papers by Gunnar Lindeberg Breakdown of academic impact, for papers by Wieslaw M. Kazmierski Breakdown of academic impact, for papers by Yonghui Zhang Breakdown of academic impact, for papers by Carston R. Wagner Breakdown of academic impact, for papers by Shashi Gujar Breakdown of academic impact, for papers by Lee M. Greenberger Breakdown of academic impact, for papers by James H. Nettles Breakdown of academic impact, for papers by Yoshito Abe